Data refresh captures progress in state reporting as Scorecard seeks to improve transparency and accountability regarding health care quality and outcomes
Today, delivering on President Trump’s Advancing American Kidney Health Executive Order, the U.S.
CMS Expands Coverage of Ambulatory Blood Pressure Monitoring (ABPM)
The Centers for Medicare and Medicaid Services (CMS) announced today that Minnesota and Nebraska have become the 23rd and 24th states who have received approval under the Trump Administration for innovative demonstration projects that increase access to treatment for opioid use disorder (OUD) and other substance use disorders (SUD).
Today the Centers for Medicare and Medicaid Services (CMS) approved Louisiana’s Medicaid State Plan Amendment (SPA) authorizing the state to negotiate supplemental rebate agreements from prescription drug manufacturers.
Today, the Centers for Medicare & Medicaid Services (CMS) announced a Notice of Funding Opportunity (insert link) that provides State Medicaid agencies with information to apply for planning grants that will aid in the treatment and recovery of substance use disorders (SUDs), including opioid use disorder (OUD).